• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration

    7/17/24 4:09:09 PM ET
    $CI
    $ELV
    $HUM
    $UNH
    Medical Specialities
    Health Care
    Medical Specialities
    Health Care
    Get the next $CI alert in real time by email

    Healthcare investors are expecting Republican presidential nominee Donald Trump to ease regulations on Medicare Advantage if the former president wins and returns to the White House.

    Under the Biden administration, the Centers for Medicare & Medicaid Services has hardened its stance on the program after it faced criticism for insurers overbilling the government and denying care to seniors too many times, the Wall Street Journal reported.

    Republicans tend to favor privatizing government services and have been friendlier to Medicare Advantage plans, a trend that investors are betting could continue under a second Trump administration. 

    Also Read: UnitedHealth Analysts Boost Their Forecasts Following Upbeat Earnings

    Regulatory easing on Medicare Advantage could also rekindle talks on possible mergers between health insurers. The Cigna Group (NYSE:CI) and Humana Inc. (NYSE:HUM) have discussed merging, but they backed away from the deal over antitrust issues and worries over Medicare, the Journal reported in November.

    Price Action: The health insurance sector gave mixed results on Wall Street. United Healthcare Group Inc. (NYSE:UNH) gained 4.44% to $573.28, while Elevance Health, Inc. (NYSE:ELV) dropped 5.95% to $520.21 and Cigna rose 1.49% to $344.76 on Wednesday.

    Exchange-traded funds that hold health insurer stocks, however, trended upward.

    • iShares U.S. Healthcare Providers ETF (NYSE:IHF) edged up 0.11%
    • The Health Care Select Sector SPDR Fund (NYSE:XLV) went up 0.45%
    • Global X Dow 30 Covered Call & Growth ETF (NYSE:DYLG) inched up 0.25%
    • SPDR Dow Jones Industrial Average ETF Trust (NYSE:DIA) gained 0.55%
    • iShares U.S. Healthcare ETF (NYSE:IYH) ticked up 0.33%.

    Read Now:

    • What Analysts Are Saying About Humana Stock

    Image created using artificial intelligence via Midjourney.

    Get the next $CI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CI
    $ELV
    $HUM
    $UNH

    CompanyDatePrice TargetRatingAnalyst
    UnitedHealth Group Incorporated
    $UNH
    4/1/2026$330.00Mkt Perform → Outperform
    Raymond James
    The Cigna Group
    $CI
    3/12/2026$358.00Mkt Perform → Outperform
    Bernstein
    Humana Inc.
    $HUM
    2/12/2026$189.00Outperform → Sector Perform
    RBC Capital Mkts
    Elevance Health Inc.
    $ELV
    2/3/2026$358.00Outperform → Sector Perform
    RBC Capital Mkts
    Humana Inc.
    $HUM
    2/2/2026$174.00Equal-Weight → Underweight
    Morgan Stanley
    Elevance Health Inc.
    $ELV
    1/8/2026$425.00Peer Perform → Outperform
    Wolfe Research
    Humana Inc.
    $HUM
    1/7/2026$290.00Overweight → Equal Weight
    Wells Fargo
    Elevance Health Inc.
    $ELV
    12/19/2025$320.00Buy → Hold
    Deutsche Bank
    More analyst ratings

    $CI
    $ELV
    $HUM
    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UnitedHealth upgraded by Raymond James with a new price target

    Raymond James upgraded UnitedHealth from Mkt Perform to Outperform and set a new price target of $330.00

    4/1/26 8:15:26 AM ET
    $UNH
    Medical Specialities
    Health Care

    The Cigna Group upgraded by Bernstein with a new price target

    Bernstein upgraded The Cigna Group from Mkt Perform to Outperform and set a new price target of $358.00

    3/12/26 8:38:26 AM ET
    $CI
    Medical Specialities
    Health Care

    Humana downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Humana from Outperform to Sector Perform and set a new price target of $189.00

    2/12/26 8:16:45 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $ELV
    $HUM
    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Collis Steven H bought $869,520 worth of shares (3,000 units at $289.84), increasing direct ownership by 469% to 3,639 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    3/6/26 8:03:27 AM ET
    $ELV
    Medical Specialities
    Health Care

    President, CenterWell Shetty Sanjay K bought $150,016 worth of Humana Common (810 units at $185.21), increasing direct ownership by 7% to 11,657 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/25/26 11:48:38 AM ET
    $HUM
    Medical Specialities
    Health Care

    Chairman & CEO Cordani David bought $999,916 worth of shares (4,134 units at $241.88) (SEC Form 4)

    4 - Cigna Group (0001739940) (Issuer)

    11/3/25 2:47:56 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    $ELV
    $HUM
    $UNH
    SEC Filings

    View All

    SEC Form DEFA14A filed by Elevance Health Inc.

    DEFA14A - Elevance Health, Inc. (0001156039) (Filer)

    3/27/26 4:21:47 PM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form DEF 14A filed by Elevance Health Inc.

    DEF 14A - Elevance Health, Inc. (0001156039) (Filer)

    3/27/26 4:21:11 PM ET
    $ELV
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by UnitedHealth Group Incorporated

    SCHEDULE 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    3/27/26 1:52:07 PM ET
    $UNH
    Medical Specialities
    Health Care

    $CI
    $ELV
    $HUM
    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Cigna Group's First Quarter 2026 Earnings Release Details

    BLOOMFIELD, Conn., April 2, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2026 financial results on Thursday, April 30, 2026, and will host a conference call the same day. First quarter 2026 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:Live Call(888) 566-1889 (Domestic)(773) 799-3989 (International)Passcode: 04302026Replay(866) 405-7290 (Domestic)(203) 369-0603 (International

    4/2/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    Elevance Health Announces Leadership Appointments to Strengthen Execution and Drive Growth

    Elevance Health, Inc. (NYSE:ELV) today announced a series of leadership appointments across its Health Benefits and Carelon organizations, positioning the company to strengthen execution, enhance operational performance, and drive continued growth across its businesses. These appointments support the continued expansion of Carelon, Elevance Health's services business, which provides a broad and expanding range of services across care, pharmacy, behavioral health, and data-driven insights to more than 90 million consumers across the healthcare system. As Carelon continues to scale, the updated leadership structure is designed to better align capabilities, accelerate decision-making, and

    3/31/26 9:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2026 Results on April 22, 2026

    Elevance Health (NYSE:ELV) will release first quarter 2026 financial results on April 22, 2026, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-391-9853 - No Access Code (Domestic Replay) 203-369-3269 - No Access Code (International Replay) The call will be available through a live webcast at www.elevancehealth.com under the "Investors" link. You may also acces

    3/30/26 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    $CI
    $ELV
    $HUM
    $UNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Nelson Andrea L

    3 - Cigna Group (0001739940) (Issuer)

    4/3/26 5:13:56 PM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form 4 filed by Shetty Sanjay K

    4 - HUMANA INC (0000049071) (Issuer)

    4/3/26 10:48:44 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 4 filed by Renaudin George Ii

    4 - HUMANA INC (0000049071) (Issuer)

    4/2/26 11:18:30 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $ELV
    $HUM
    $UNH
    Financials

    Live finance-specific insights

    View All

    The Cigna Group's First Quarter 2026 Earnings Release Details

    BLOOMFIELD, Conn., April 2, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2026 financial results on Thursday, April 30, 2026, and will host a conference call the same day. First quarter 2026 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:Live Call(888) 566-1889 (Domestic)(773) 799-3989 (International)Passcode: 04302026Replay(866) 405-7290 (Domestic)(203) 369-0603 (International

    4/2/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2026 Results on April 22, 2026

    Elevance Health (NYSE:ELV) will release first quarter 2026 financial results on April 22, 2026, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-391-9853 - No Access Code (Domestic Replay) 203-369-3269 - No Access Code (International Replay) The call will be available through a live webcast at www.elevancehealth.com under the "Investors" link. You may also acces

    3/30/26 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Humana Inc. to Release First Quarter 2026 Results on April 29, 2026

    Humana Inc. (NYSE:HUM) will release its financial results for the first quarter 2026 (1Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 1Q26 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BId1413c4c078343e28841e18c372f7b58.

    3/30/26 4:30:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $ELV
    $HUM
    $UNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Elevance Health Inc.

    SC 13G/A - Elevance Health, Inc. (0001156039) (Subject)

    11/14/24 1:22:35 PM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by The Cigna Group

    SC 13G - Cigna Group (0001739940) (Subject)

    11/12/24 9:55:14 AM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/16/24 4:29:43 PM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $ELV
    $HUM
    $UNH
    Leadership Updates

    Live Leadership Updates

    View All

    The Cigna Group Announces President & COO Brian Evanko to Succeed David M. Cordani as Chief Executive Officer

    Cordani to retire as chief executive officer on July 1, 2026, and will serve as executive chair of The Cigna Group Board of DirectorsEvanko elected to the company's Board of DirectorsCompany reaffirms 2026 Financial OutlookBLOOMFIELD, Conn., March 3, 2026 /PRNewswire/ -- The Cigna Group (NYSE: CI) today announced that David M. Cordani will retire as chief executive officer effective July 1, 2026, and become executive chair of The Cigna Group's Board of Directors. Brian Evanko, current president and chief operating officer, will succeed Cordani as CEO. Throughout his tenure—inclu

    3/3/26 7:30:00 AM ET
    $CI
    Medical Specialities
    Health Care

    Elevance Health Announces Management Changes; CFO Mark Kaye to Expand Responsibilities to Include Carelon and Felicia Norwood to Lead Consolidated Health Benefits Organization

    Elevance Health, Inc. (NYSE:ELV) today announced management changes designed to simplify decision-making and strengthen execution across Carelon and Health Benefits. As part of these changes, Mark Kaye, Executive Vice President and Chief Financial Officer, will expand his responsibilities to include oversight of Carelon, the Company's healthcare services operations including pharmacy services, behavioral health, value-based care, and care delivery capabilities. Carelon plays a critical role in advancing the Company's strategy to lower the cost of care. Carelon's operating priorities and client commitments remain unchanged. Felicia Norwood, Executive Vice President and Chief Health Benef

    2/26/26 3:02:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    VINCENT COUNTRY SAFE ZONE ACTIVITY DAY PRESENTED BY CIGNA HEALTHCARE DELIVERS SUPER BOWL WEEK FUN, NFL FLAG FOOTBALL, AND WELLNESS TO OAKLAND STUDENTS

    Corporate, Nonprofit, and Philanthropic Partners Collaborated to Provide Transformative Experiences and Lasting Resources at Burckhalter Elementary School OAKLAND, Calif., Feb. 3, 2026 /PRNewswire/ -- Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare, a flagship initiative of Love Thy Neighbor CDC co-founded by NFL Executive and Legend Troy Vincent, Sr. and his wife, author and chef Tommi A. Vincent, took place Tuesday, February 3, at Burckhalter Elementary School in Oakland, CA. The ninth annual event, themed Dreams Grow Here, delivered a full day of fun, food, wellness, and engaging sports activities, including NFL FLAG, for more than 200 Pre-K through fifth-grade studen

    2/3/26 8:17:00 PM ET
    $CI
    Medical Specialities
    Health Care